Investing.com - Minerva Neurosciences reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Minerva Neurosciences announced earnings per share of $-1.290 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-1.380 on revenue of $0.
Minerva Neurosciences shares are down 28.9% from the beginning of the year , still down 79.22% from its 52 week high of $15.27 set on Wednesday, August 31, 2022.
Minerva Neurosciences shares gained 5.94% in intra-day trade the report.
Minerva Neurosciences follows other major Healthcare sector earnings this month
Minerva Neurosciences's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar